Logistics company UPS is to launch a new healthcare facility in Dublin, which will create 30 jobs.
The new facility will feature nearly 6,000 square metres of healthcare-dedicated space to connect the country's growing pharmaceutical and medical technology industries to its smart global logistics network that serves customers in over 220 countries and territories.
It is due to open in late 2023.
UPS Healthcare said its new Dublin facility will support the country's pharmaceutical and medical device industries in delivering next generation biologics, critical vaccines and vital healthcare equipment to patients around the world.
The company said the investment shows its commitment to the Irish market and support for its long-term export growth.
80% of pharmaceutical drugs in the European Union require cold-chain logistical support and temperature-controlled transportation.
More than 50% of all new drugs in the global pharmaceutical pipeline are cutting edge biomedical drugs - such as vaccines - that tend to be temperature-sensitive.
Cathy O'Brien, UPS Healthcare's Vice President for International Sales, said the latest investment by UPS in Ireland is a demonstration of its commitment to enabling truly global healthcare supply chains.
"Our new facility supports the quality and regulatory needs of manufacturers, many of whom are providing critical upstream activity, and we provide them with resiliency and scale," Ms O'Brien said.
"UPS Healthcare is now offering the first truly dedicated freight, small parcel and logistics offering in Ireland, including cold chain management services," she said.
"Ireland is a world leader in research, biologics and healthcare innovation, and we are confident that our clinical to commercial service offering will drive value for the Irish healthcare and economic ecosystem in the years to come," she added,
Martin Shanahan, the chief executive of IDA Ireland, said the development from UPS will support the thriving, export led life science sector here which supplies lifesaving medicines to patients all over the world.
